Early Discontinuation of Dual-Antiplatelet Therapy with SYNERGY™ Stents in High-Risk Patients Undergoing Complex PCI
As more elderly and co-morbid patients require percutaneous revascularization, 1 year of dual-antiplatelet therapy (DAPT) becomes concerning. SYNERGY™ stents allow for early cessation of DAPT.
Rotational atherectomy: You will never regret using it!
The contemporary RA technique aims to smoothen the lumen and disconnect the calcified coronary ring, thus leaving the way clear for further balloon dilatation and stent implantation. Dr. Teresa Strisciuglio and Dr. Emanuele Barbato illustrate the advantages deriving from the contemporary rotational atherectomy technique.
Synergy™ Stent: ST Rates from the Academic Research Consortium
According to the Academic Research Consortium, SYNERGY™ has demonstrated very low stent thrombosis rates across multiple clinical trials. Data in the table below show that Synergy™ Stent, with its abluminal and bioabsorbable polymer has reported consistently low sub-acute, late & very late ST in 18,000 patients across 9 studies.